NCT06908252View on ClinicalTrials.gov

MAPS PrEP Van Study

PHASE4RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 17, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

HIV Infection

Interventions

DRUG

Pre-Exposure Prophylaxis (PrEP)

Oral Pre-Exposure Prophylaxis (PrEP) pills

Trial Locations (1)

27701

RECRUITING

Duke Department of Population Health Sciences, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Duke University

OTHER